LGALS3BP and nonpapillary renal cell carcinoma: In particular, in a cohort of 512 patients with ccRCC included in the TCGA PanCancer Atlas database, the median disease-specific OS was significantly shorter in patients with high LGALS3BP (EXP > 1) compared to those with low LGALS3BP (EXP < 1) (56.68 months vs not reached, p < 0.001) (Fig. 5A).